Dubai, 8 September 2026 – Hogan Lovells Cadwalader acted as international counsel to the underwriters, JM Financial, Avendus Capital, Motilal Oswal Investment Advisors, and Nomura Financial Advisory & Securities, on the US$209 million IPO of Symbiotec Pharmalab Limited, a pharmaceutical and biotechnology company with a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients.
The IPO drew substantial interest from anchor investors as well as retail investors and was oversubscribed by 75.08 times.
The Hogan Lovells Cadwalader Capital Markets team was led by Biswajit Chatterjee, Head of the India Practice and Dubai Office Managing Partner, with support from counsel Varun Jetly, and senior associates Suchisubhra Sarkar and Aditya Dsouza.
About Hogan Lovells Cadwalader India practice
Hogan Lovells Cadwalader has built a market-leading India practice, drawing on the team’s extensive experience, deep local relationships and in-depth market knowledge. Our dedicated India team, spanning our global network, supports Indian and foreign clients in exploring investment opportunities, raising capital, business restructuring, international trade, developing and financing infrastructure projects, cross-border investigations and compliance, and resolving disputes in and outside of India. As trusted legal advisors, we are recognized for an innovative approach to thought leadership, delivering timely and comprehensive insights on legal developments that shape our clients’ strategies and long-term business goals, as well as, for our incisive advice and actionable outcomes.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.